In recent years, GPR37 has garnered increasing attention for its involvement in a variety of CNS disorders, including Parkinson’s disease, multiple sclerosis, stroke, glioma, autism spectrum disorder (ASD), and inflammatory pain (Wang et al., 2021; Guo D. et al., 2022; Zhang et al., 2024). Here, GPR37 is linked to glioma.